HCKT Hackett delivers narrow Q4 2025 earnings beat shares slip 053 percent on muted investor reaction What nobody tells you about PCM Fund PCM stock Edges Higher 20260503 Vanguard Energy ETF VDE Poised for Outperformance Amid Sustained Global Energy Supply Constraints AGX Argan reports 737 percent EPS beat for Q1 2026 shares dip slightly in todays trading Sonic Automotive SAH Q1 2026 Beat Revenue NA EPS Exceeds by Significant Jayud JYD Stock Jumps 137 Approaching 545 20260515 Market Update Industrial and Tech Stocks in Focus as Sector Rotation Continues Base58Labs Launches BASISpro a New Crypto Arbitrage Platform for Active Traders Consumer Sentiment Drops to Record Low in May as IranDriven Gas Prices Weigh on Outlook WTI Crude Oil Forecast Asymmetric Market Reactions to Iran Developments Persist SupplySide Constraints and Weather Patterns Cloud Indias Macroeconomic Outlook US Productivity Growth Slows in Q4 as Labor Costs Rise Fed Implications Were Expanding the Cinematic Toolbox AI Fault Lines on Show at Cannes US Jobless Claims Remain Low Signaling Continued Labor Market Resilience QFIN Q4 2025 Earnings Slight EPS Miss Amid Positive Stock Reaction RNG Q1 2026 Earnings EPS Beats Estimates Narrowly as Stock Pulls Back SENEB Q1 2026 Earnings Strong EPS of 619 Reported No Analyst Estimates Available NEWTG Q1 2026 Earnings EPS Misses Estimates Company Navigates Shifting Interest Rate Environment PSBD Q1 2026 Earnings Significant EPS Miss Driven by Unrealized Losses BEBE Q3 2016 Earnings EPS Plunges 194 Below Estimates as Operating Losses Deepen Roman DBDR Acquisition Corp II DRDB Holds Steady at 1052 SPAC Trading in Tight Range Oceaneering International OII Edges Higher as Stock Nears Key Support Zone SFL Corporation Ltd Slides 15 as Resistance Holds Firm at 1306 Namib Minerals NAMM Gains 438 as Shares Approach Key Resistance Level Santacruz Silver Mining SCZM Declines 193 as Shares Test Support Near 750 European Shares Climb to OneMonth High on Tech Rally and Geopolitical Optimism INFU Q1 2026 Earnings EPS Surpasses Estimates by 466 Shares Dip Slightly Nasus Pharma NSRX Gains 389 as Biotech Investors Eye Key Resistance